Screener
Maravai LifeSciences Holdings, Inc. MRVI Finance Lease Liabilities
Finance Lease Liabilities at other companies
Other financials
Where this comes from
Reported directly by Maravai LifeSciences Holdings, Inc. in its filing.
Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityNoncurrent.
The source filing: Maravai LifeSciences Holdings, Inc.’s 10-Q, filed August 7, 2026. Open the filing →
- Filed
- Aug 7, 2026, 4:03 PM EDT
- Fiscal quarter
- Q2 FY2026
- Calendar quarter
- Q2 2026
- Accession
- 0001823239-26-000059
FAQ
- What is Maravai LifeSciences Holdings, Inc.'s finance lease liabilities?
- Maravai LifeSciences Holdings, Inc. (MRVI) reported finance lease liabilities of $29.59M in Q2 2026.
- How has Maravai LifeSciences Holdings, Inc.'s finance lease liabilities changed year-over-year?
- Maravai LifeSciences Holdings, Inc.'s finance lease liabilities decreased by 3.5% year-over-year, from $30.65M to $29.59M.
- What is the long-term trend for Maravai LifeSciences Holdings, Inc.'s finance lease liabilities?
- Over 4 years (2020 to 2025), Maravai LifeSciences Holdings, Inc.'s finance lease liabilities has grown at a -14.4% compound annual growth rate (CAGR), from $56.17M to $30.14M.
- What does finance lease liabilities mean?
- Present value of future payments on leases classified as finance leases under ASC 842 — treated similarly to debt on the balance sheet.
Ask your AI about Maravai LifeSciences Holdings, Inc.'s finance lease liabilities.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude